Contrast sensitivity mediated by inferred magno- and parvocellular pathways in type 2 diabetics with and without nonproliferative retinopathy

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 1151-1155

  Gualtieri, Mirella ^a   Bandeira, Marcio ^a   Hamer, Russell David ^a,b   Damico, Francisco Max ^a   Moura, Ana Laura Araújo ^a   Ventura, Dora Fix ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTRAST SENSITIVITY; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; LUMINANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULSED PEDESTAL PARADIGM; STEADY PEDESTAL PARADIGM; STIMULUS DURATION; STIMULUS RESPONSE; TIME; VISUAL STIMULATION; VISUAL THRESHOLD; GENICULATE BODY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA GANGLION CELL; VISUAL DISORDER; VISUAL SYSTEM;

CONTRAST SENSITIVITY; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENICULATE BODIES; HUMANS; MALE; MIDDLE AGED; RETINAL GANGLION CELLS; VISION DISORDERS; VISUAL PATHWAYS;

EID: 79953282728     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3705     Document Type: Article

References (42)

1. Bangstad HJ, Brinchmann-Hansen O, Hultgren S, Dahl-Jorgensen K, Hanssen KF. Impaired contrast sensitivity in adolescents and young type 1 insulin-dependent diabetic patients with microalbuminuria. Acta Ophthalmol. 1994;72:668-673.
2. Dean FM, Arden GB, Dornhorst A. Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin-dependent diabetic subjects. Br J Ophthalmol. 1997;81:27-30.
3. Di Leo MAS, Caputo S, Falsini B, et al. Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care. 1992;15:620-624.
4. Ewing FME, Deary IJ, Strachan MWJ, Frier BM. Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision. Endocr Rev. 1998;19:462-476.
5. Harris A, Arend O, Danis RP, Evans D, Wolf S, Martin BJ. Hyperoxia improves contrast sensitivity in early diabetic retinopathy. Br J Ophthalmol. 1996;80:209-213.
6. Verrotti A, Lobefalo L, Petitti MT, et al. Relationship between contrast sensitivity and metabolic control in diabetics with and without retinopathy. Ann Med. 1998;30:369-374.
7. Cusick M, Sangiovanni JP, Chew EY, et al. Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes, Am J Ophthalmol. 2005;139: 1042-1050.
8. West CG, Gildengorin G, Haegerstrom-Portnoy G, Schneck ME, Lott L, Brabyn JA. Is vision function related to physical functional ability in older adults? J Am Geriatr Soc. 2002;50:136-145.
9. Arend O, Remky A, Evans D, Stuber R, Harris A. Contrast sensitivity loss is coupled with capillary dropout in patients with diabetes. Invest Ophthalmol Vis Sci. 1997;38:1819-1824.
10. North RV, Farrell U, Banford D, et al. Visual function in young IDDM patients over 8 years of age; a 4-year longitudinal study. Diabetes Care. 1997;20:1724-1730.
11. Sukha AY, Rubin A. High, medium, and low contrast visual acuities in diabetic retinal disease. Optometry Vis Sci. 2009;86:1086-1095.
12. Dosso AA, Yenice-Ustun F, Sommerhalder J, Golay A, Morel Y, Leuenberger PM. Contrast sensitivity in obese dyslipidemic patients with insulin resistance. Arch Ophthalmol. 1998;116:1316-1320.
13. Fletcher EL, Phipps JA, Ward MM, Puthussery T, Wilkinson-Berka JL. Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharmaceut Design. 2007;13:2699-2712.
14. Kurtenbach A, Langrova H, Zrenner E. Multifocal oscillatory potentials in type 1 diabetes without retinopathy. Invest OphthalmolVis Sci. 2000;41:3234-3241.
15. Lieth E, Gardner TW, Barber AJ, Antonetti DA. Retinal neurodegeneration: early pathology in diabetes. Clin Exp Ophthalmol. 2000; 26:3-8.
16. Feitosa-Santana C, Oiwa N, Paramei G, et al. Color space distortions in patients with type 2 diabetes mellitus. Vis Neurosci. 2006;23:663-668.
17. Ventura DF, Nishi M, Bernicki M, et al. Early vision loss in diabetic patients assessed by the Cambridge Colour Test. In: Mollon JD, Pokorny J, Knoblauch K, eds. Normal and Defective Color Vision. Oxford UK: Oxford University Press; 2003:395-403.
18. Feitosa-Santana C, Paramei GV, Nishi M, Gualtieri M, Costa MF, Ventura DF. Color vision impairment in type 2 diabetes assessed by the D-15d test and the Cambridge Colour Test. OphthalmicPhysiol Opt. 2010;30:717-723.
19. Pokorny J, Smith VC. Psychophysical signatures associated with magnocellular and parvocellular pathway contrast gain. J Opt Soc Am A Optics Image Sci Vis. 1997;14:2477-2486.
20. Kaplan E, Shapley RM. The primate retina contains two types of ganglion cells, with high and low contrast sensitivity. Proc Natl Acad Sci USA. 1986;83:2755-2757.
21. Alexander KR, Barnes CS, Fishman GA, Pokorny J, Smith VC. Contrast sensitivity deficits in inferred magnocellular and parvocellular pathways in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2004;45:4510-4519.
22. Gualtieri M, Bandeira M, Hamer RD, et al. Psychophysical analysis of contrast processing segregated into magnocellular and parvocellular systems in asymptomatic carriers of 11778 Leber's hereditary optic neuropathy. Vis Neurosci. 2008;25:469-474.
23. McKendrick AM, Badcock DR. Contrast-processing dysfunction in both magnocellular and parvocellular pathways in migraineurs with or without aura. Invest Ophthalmol Vis Sci. 2003;44:442-448.
24. McKendrick AM, Badcock DR, Morgan WH. Psychophysical measurement of neural adaptation abnormalities in magnocellular and parvocellular pathways in glaucoma. Invest Ophthalmol Vis Sci. 2004;45:1846-1853.
25. Zele AJ, Pokorny J, Lee DY, Ireland D. Anisometropic amblyopia: spatial contrast sensitivity deficits in inferred magnocellular and parvocellular vision. Invest Ophthalmol Vis Sci. 2007;48:3622-3631.
26. Krauskopf J, Mollon JD. The independence of the temporal integration properties of individual chromatic mechanisms in the human eye. J Physiol. 1971;219:611-623.
27. Barlow HB. Temporal and spatial summation in human vision at different background intensities. J Physiol. 1958;141:337-350.
28. Gorea A, Tyler CW. New look at Bloch's law for contrast. J Opt Soc Am A. 1986;3:52-61.
29. Herrick RM. Foveal luminance discrimination as a function of the duration of the decrement or increment in luminance. J Comp Physiol Psychol. 1956;49:437-443.
30. Roufs JA. Dynamic properties of vision, II: theoretical relationships between flicker and flash thresholds. Vision Res. 1972;12:279-292.
31. Kahneman D, Normann J. The time-intensity relation in visual perception as a function of observer's task. J Exp Psychol. 1964; 68:215-220.
32. Watson, AB. Temporal sensitivity. In: Boff K, Kaufman L, Thomas J, eds. Handbook of Perception and Human Performance. New York: Wiley; 1986:6-1, 6-43.
33. Swanson WH, Ueno T, Smith VC, Pokorny J. Temporal modulation sensitivity and pulse-detection thresholds for chromatic and luminance perturbations. J Opt Soc Am A. 1987;4:1992-2005.
34. Shapley RM, Victor JD. The effect of contrast on the transfer properties of cat retinal ganglion cells. J Physiol. 1978;285:275-298.
35. Benardete EA, Kaplan E, Knight BW. Contrast gain control in the primate retina: P cells are not X-like, some M cells are. Vis Neurosci. 1992;8:483-486.
36. Benardete EA, Kaplan E. The dynamics of primate M retinal ganglion cells. Vis Neurosci. 1999;16:355-368.
37. Lee BB, Sun H, Zucchini W. The temporal properties of the response of macaque ganglion cells and central mechanisms of flicker detection. J Vis. 2007;15:1-16.
38. El-Asrar AMA, Dralanas L, Missotten, Al-Jadaan IA, Geboes K. Expression of apoptosis marked in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 2004;45:2760-2766.
39. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:283-290.
40. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW, The Penn State Retina Research Group. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol. 2002;47:S253-S262.
41. Klein JP, Waxman SG. The brain in diabetes: molecular changes in neurons and their implications for end-organ damage. Lancet Neurol. 2003;2:548-554.
42. Wessels AM, Scheltens P, Barkhof F, Heine RJ. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Eur J Pharmacol. 2008;585:88-96.